Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Benign prostatic hyperplasia (BPH) is one of the most common diseases affecting aging men with limited therapeutic options. In this study, the authors describe the molecular characterization of BPH performing genomic, transcriptomic and epigenetic analysis of 18 BPH cases.
Guardado en:
Autores principales: | Deli Liu, Jonathan E. Shoag, Daniel Poliak, Ramy S. Goueli, Vaishali Ravikumar, David Redmond, Aram Vosoughi, Jacqueline Fontugne, Heng Pan, Daniel Lee, Domonique Thomas, Keyan Salari, Zongwei Wang, Alessandro Romanel, Alexis Te, Richard Lee, Bilal Chughtai, Aria F. Olumi, Juan Miguel Mosquera, Francesca Demichelis, Olivier Elemento, Mark A. Rubin, Andrea Sboner, Christopher E. Barbieri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e8baf4a938944f0fbc66a64df0469d3e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multiplatform Physiologic and Metabolic Phenotyping Reveals Microbial Toxicity
por: Jingwei Cai, et al.
Publicado: (2018) -
Identification and quantification of honeybee venom constituents by multiplatform metabolomics
por: Agnieszka Klupczynska, et al.
Publicado: (2020) -
The dawning era of personalized medicine exposes a gap in medical education.
por: Keyan Salari
Publicado: (2009) -
Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma
por: Stephen T. Magill, et al.
Publicado: (2020) -
Prognostic biomarkers of Parkinson’s disease in the Spanish EPIC cohort: a multiplatform metabolomics approach
por: Carolina Gonzalez-Riano, et al.
Publicado: (2021)